CA2 and ovarian carcinoma: Other BCL3 transcriptional targets include PD-L1 (Programmed Cell Death 1 Ligand 1) and CAII (Carbonic Anhydrase II) that mediate cell proliferation and resistance to alkylating agents in ovarian cancer and gliomas, respectively (29, 30).